Cytomegalovirus and Schizophrenia | The British Journal of Psychiatry | Cambridge Core (original) (raw)

Summary

Cerebrospinal fluid (CSF) from 20 chronically hospitalised male schizophrenics and from 12 patients admitted with acute schizophrenia were examined for antibodies against cytomegalovirus. A sensitive and specific enzyme-immunoassay was used to detect IgG or I g M classes of antibodies in the CSF of the schizophrenic patients and often orthopaedic patients, who served as controls. No significant amounts of I g M antibody were found in the CSF of either group. A significant titre of IgG was found in only one of the 32 schizophrenics, an acute patient, but in four of the orthopaedic patients. The results do not support an association of cytomegalovirus infection with schizophrenia; if such an association occurs, it must be unusual.

References

Albrecht, P., Torrey, E. F., Boone, E., Hicks, J. & Daniel, N. (1980) Raised cytomegalovirus antibody level in cerebrospinal fluid of schizophrenic patients. In Lancet, ii, 769–772.Google Scholar

Aulakh, G. S., Kleinman, J. E., Aulakh, H. S., Albrecht, P., Torrey, E. F. & Wyatt, R. J. (1981) Search for cytomegalovirus in schizophrenic brain tissue. Proceedings of the Society for Experimental Biology and Medicine, 167, 172–174.Google Scholar

Booth, J. C. (1983) The use of the enzyme-linked immunosorbent assay (ELISA) technique in clinical virology. In Recent Advances in Clinical Virology, 3rd Edition (ed. Waterson, A. P.) London: Churchill Livingstone.Google Scholar

Crow, T. J., Ferrier, I. N., Johnstone, E. C., Macmillan, J. F., Owens, P. G., Parry, R. P. & Tyrell, D. A. (1979) Characteristics of patients with schizophrenia or neurological disorder and virus-like agent in the cerebrospinal fluid. Lancet, i, 842–844.Google Scholar

Delisi, L. E., Weinberger, D. R., Potkin, S., Neckers, L. M., Shilling, D. J. & Wyatt, R. J. (1981) Quantitative determination of immunoglobulins in CSF and plasma of chronic schizophrenic patients. British Journal of Psychiatry, 139, 513–518.Google Scholar

Friedman, S. B., Cohen, J. & Iker, H. (1967) Antibody response to cholera vaccine. Differences between depressed, schizophrenic and normal subjects. Archives of General Psychiatry, 16, 312.Google Scholar

Gotlieb-Stematsky, T., Zonis, J., Arlazoroff, A., Mozes, T., Sigal, M. & Szekely, A. G. (1981) Antibodies to Epstein-Barr virus. Herpes simplex type 1, Cytomegalovirus and measles virus in psychiatric patients. Archives of Virology, 67, 333–339.Google Scholar

Heath, R. G. & Krupp, I. M. (1967) Schizophrenia as an immunologic disorder. I. Demonstration of anti-brain antibodies. Archives of General Psychiatry, 16, 1–9.Google Scholar

Hermann, J. E., Hendry, R. M. & Collins, M. F. (1979) Factors involved in enzyme linked immunoassay of viruses and evaluation of the method for indentification of enteroviruses. Journal of Microbiology, 10, 210–217.Google Scholar

Katz, M. G. & Crowell, R. L. (1980) Indirect enzyme-linked immunosorbent assay (ELISA) for the detection of foxsackie group B antibodies. Journal of General Virology, 48, 225–229.Google Scholar

Pulkinnen, E. (1977) Immunoglobulins, psychopathology and prognosis in schizophrenia. Acta Psychiatrica Scandinavia, 56, 173–182.Google Scholar

Sugarman, A. A., Southern, D. L. & Curran, J. F. (1982) A study of antibody levels in alcoholic, depressive and schizophrenic patients. Annals of Allergy, 48, 166–171.Google Scholar

Torrey, E. F. (1973) Slow and latent viruses in schizophrenia. Lancet, ii, 22–24.Google Scholar

Torrey, E. F., Peterson, M. R., Brannon, W. L., Carpenter, W. T., Post, R. M. & Van Kammen, D. P. (1978) Immunoglobulins and viral antibodies in psychiatric patients. British Journal of Psychiatry, 132, 341–348.CrossRefGoogle Scholar

Torrey, E. F., Yolken, R. H. & Winfrey, C. J. (1982) Cytomegalovirus antibodies in cerebrospinal fluid of schizophrenic patients detected by enzyme-immunoassay. Science, 216, 892–894.Google Scholar

Tyrell, D. A., Parry, R. P., Crow, T. J., Johnstone, E. C & Ferrier, I. N. (1979) Possible virus in schizophrenia and some neurological disorders. Lancet, i, 839–841.CrossRefGoogle Scholar

Wing, J. K., Cooper, J. & Sartorious, N. (1974) The Measurement and Classification of Psychiatric Symplons. London: Cambridge University Press.Google Scholar